174 related articles for article (PubMed ID: 16216175)
21. Macrolides for the treatment of chronic sinusitis, asthma, and COPD.
Gotfried MH
Chest; 2004 Feb; 125(2 Suppl):52S-60S; quiz 60S-61S. PubMed ID: 14872001
[TBL] [Abstract][Full Text] [Related]
22. [A progress of macrolides therapy for chronic rhinosinusitis].
Shen S; Wang CS
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):717-722. PubMed ID: 29771095
[TBL] [Abstract][Full Text] [Related]
23. Potential new avenues of treatment for chronic rhinosinusitis: an anti-inflammatory approach.
Statham MM; Seiden A
Otolaryngol Clin North Am; 2005 Dec; 38(6):1351-65, xi. PubMed ID: 16326190
[TBL] [Abstract][Full Text] [Related]
24. [Macrolide therapy on nasal mucosal persistent refractory inflammation after endoscopic sinus surgery].
Zuo KJ; Xu G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):718-22. PubMed ID: 22177037
[TBL] [Abstract][Full Text] [Related]
25. Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions.
Ranford D; Hopkins C
Expert Opin Drug Saf; 2021 Oct; 20(10):1177-1189. PubMed ID: 33957840
[No Abstract] [Full Text] [Related]
26. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
Majima Y
Am J Med; 2004 Nov; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.
Cervin A; Wallwork B
Curr Allergy Asthma Rep; 2014 Mar; 14(3):416. PubMed ID: 24429901
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of macrolide responders in persistent post-surgical rhinosinusitis.
Oakley GM; Christensen JM; Sacks R; Earls P; Harvey RJ
Rhinology; 2018 Jun; 56(2):111-117. PubMed ID: 29476191
[TBL] [Abstract][Full Text] [Related]
29. [A randomized controlled study of treating chronic rhinosinusitis with macrolides].
Li Y; Wu T
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Sep; 28(17):1289-91. PubMed ID: 25522560
[TBL] [Abstract][Full Text] [Related]
30. Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis.
Haxel BR; Clemens M; Karaiskaki N; Dippold U; Kettern L; Mann WJ
Laryngoscope; 2015 May; 125(5):1048-55. PubMed ID: 25425539
[TBL] [Abstract][Full Text] [Related]
31. [On the problem of medicamentous therapy of chronic polypous rhinosinusitis].
Volkov AG; Trofimenko SL; Riabtseva OA; Bodzhokov AR
Vestn Otorinolaringol; 2010; (4):41-4. PubMed ID: 21105345
[TBL] [Abstract][Full Text] [Related]
32. Impact of Biologic Therapies on Surgery for Chronic Rhinosinusitis With Nasal Polyposis.
Chandra R
Ear Nose Throat J; 2021 Sep; 100(8):555-556. PubMed ID: 34384031
[No Abstract] [Full Text] [Related]
33. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging.
Damm M; Jungehülsing M; Eckel HE; Schmidt M; Theissen P
Otolaryngol Head Neck Surg; 1999 Apr; 120(4):517-23. PubMed ID: 10187944
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment with clarithromycin and carbocisteine improves lung function in chronic cough patients with chronic rhinosinusitis.
Kariya S; Okano M; Higaki T; Makihara S; Tachibana T; Nishizaki K
Am J Otolaryngol; 2020; 41(1):102315. PubMed ID: 31732313
[TBL] [Abstract][Full Text] [Related]
35. The inhibitory effects of macrolide antibiotics on bone remodeling in chronic rhinosinusitis.
Park CS; Park YS; Park YJ; Cho JH; Kang JM; Kim SY
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):274-9. PubMed ID: 17666255
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis.
Gillespie MB; Osguthorpe JD
Curr Allergy Asthma Rep; 2004 Nov; 4(6):478-85. PubMed ID: 15462715
[TBL] [Abstract][Full Text] [Related]
37. Long-term antibiotics for Chronic Rhinosinusitis: changing views.
Fokkens WJ
Rhinology; 2019 Aug; 57(4):241. PubMed ID: 31374113
[TBL] [Abstract][Full Text] [Related]
38. Oral antibiotics and the management of chronic sinusitis: what do we know?
Russell PT; Bekeny JR
Curr Opin Otolaryngol Head Neck Surg; 2014 Feb; 22(1):22-6. PubMed ID: 24322657
[TBL] [Abstract][Full Text] [Related]
39. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records.
Williamson E; Denaxas S; Morris S; Clarke CS; Thomas M; Evans H; Direk K; Gonzalez-Izquierdo A; Little P; Lund V; Blackshaw H; Schilder A; Philpott C; Hopkins C; Carpenter J; Programme Team OBOTM
Rhinology; 2019 Aug; 57(4):252-260. PubMed ID: 30928998
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.
Ponikau JU; Sherris DA; Weaver A; Kita H
J Allergy Clin Immunol; 2005 Jan; 115(1):125-31. PubMed ID: 15637558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
